v3.25.2
SCHEDULE OF OPERATIONS, ASSETS AND CAPITAL EXPENDITURES FOR OUR BUSINESS SEGMENTS (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2025
Jun. 30, 2024
Segment Reporting Information [Line Items]            
Net revenue $ 25,830,834   $ 20,158,823   $ 49,264,930 $ 38,695,461
Cost of goods sold 1,937,282   2,008,686   3,772,249 3,898,732
Selling, general and administrative 21,553,194   18,957,608   42,993,804 [1] 35,149,867 [1]
Research and development 1,257,475   985,651   2,371,613 1,931,949
Depreciation and amortization 1,114,231   1,105,507   2,238,641 2,210,927
Change in fair value of earnout liabilities   (13,773)   (79,451)
Other expense [2] 1,987,050   644,346   3,434,404 911,682
Net loss (2,018,398) $ (3,527,383) (3,529,202) $ (1,799,043) (5,545,781) (5,328,245)
Segment Adjusted EBITDA 2,664,840   592,181   3,322,808 903,602
Sanara Surgical [Member]            
Segment Reporting Information [Line Items]            
Net revenue 25,804,252   20,158,823   49,238,348 38,695,461
Cost of goods sold 1,937,282   2,008,686   3,772,249 3,898,732
Selling, general and administrative 19,634,319   18,349,924   38,763,527 [1] 34,032,964 [1]
Research and development 1,056,796   582,443   2,007,155 1,161,424
Depreciation and amortization 681,525   698,407   1,370,096 1,396,908
Change in fair value of earnout liabilities   89,330   (14,451)
Other expense [2] 1,987,050   644,346   3,433,146 911,682
Net loss 507,280   (2,214,313)   (107,825) (2,691,798)
Segment Adjusted EBITDA 4,719,827   1,393,959   7,414,885 2,532,145
THP [Member]            
Segment Reporting Information [Line Items]            
Net revenue 26,582     26,582
Cost of goods sold    
Selling, general and administrative 1,918,875   607,684   4,230,277 [1] 1,116,903 [1]
Research and development 200,679   403,208   364,458 770,525
Depreciation and amortization 432,706 [3]   407,100   868,545 [3] 814,019
Change in fair value of earnout liabilities [3]   (103,103)   [3] (65,000)
Other expense [2]     1,258
Net loss (2,525,678) [3]   (1,314,889)   (5,437,956) [3] (2,636,447)
Segment Adjusted EBITDA $ (2,054,987) [3]   $ (801,778)   $ (4,092,077) [3] $ (1,628,543)
[1] For the six months ended June 30, 2024, $90,293 of selling, general and administrative expenses were reclassified from the Sanara Surgical segment to the THP segment.
[2] For the three months ended June 30, 2025, other expense included interest expense and share of losses from equity method investments. For the three months ended June 30, 2024, other expense included interest expense. For the six months ended June 30, 2025, other expense included interest expense and share of losses from equity method investments, offset by interest income and gain on disposal of property and equipment. For the six months ended June 30, 2024, other expense included interest expense.
[3] The THP segment does not include $1.7 million and $3.4 million of internal use software costs capitalized during the three and six months ended June 30, 2025, respectively.